Chojnacka M, Diamond B, Ziccheddu B, Rustad E, Maclachlan K, Papadimitriou M, Boyle EM, Blaney P, Usmani S, Morgan G, Landgren O, Maura F(2024) Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma Clin Cancer Res, 30(3), 575-585 DOI 10.1158/1078-0432.CCR-23-1045, PubMed 37939148
Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl Tet al.(2023) A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo Nat Cancer, 4(10), 1474-1490 DOI 10.1038/s43018-023-00642-8, PubMed 37783807
Hauge Okholm TL, Kamstrup AB, Nielsen MM, Hollensen AK, Graversgaard ML, Sørensen MH, Kristensen LS, Vang S, Park SS, Yeo GW, Dyrskjøt L, Kjems J, Pedersen JS, Damgaard CK(2024) circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA bioRxiv DOI 10.1101/2023.09.14.557527, PubMed 37745562